Literature DB >> 24508256

Accumulated SET protein up-regulates and interacts with hnRNPK, increasing its binding to nucleic acids, the Bcl-xS repression, and cellular proliferation.

Luciana O Almeida1, Cristiana B Garcia1, Flavia A Matos-Silva1, Carlos Curti2, Andréia M Leopoldino3.   

Abstract

SET and hnRNPK are proteins involved in gene expression and regulation of cellular signaling. We previously demonstrated that SET accumulates in head and neck squamous cell carcinoma (HNSCC); hnRNPK is a prognostic marker in cancer. Here, we postulate that SET and hnRNPK proteins interact to promote tumorigenesis. We performed studies in HEK293 and HNSCC (HN6, HN12, and HN13) cell lines with SET/hnRNPK overexpression and knockdown, respectively. We found that SET and/or hnRNPK protein accumulation increased cellular proliferation. SET accumulation up-regulated hnRNPK mRNA and total/phosphorylated protein, promoted hnRNPK nuclear location, and reduced Bcl-x mRNA levels. SET protein directly interacted with hnRNPK, increasing both its binding to nucleic acids and Bcl-xS repression. We propose that hnRNPK should be a new target of SET and that SET-hnRNPK interaction, in turn, has potential implications in cell survival and malignant transformation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Bcl-xS; HNSCC; Interaction DNA-protein; SET; SET–hnRNPK; hnRNPK

Mesh:

Substances:

Year:  2014        PMID: 24508256     DOI: 10.1016/j.bbrc.2014.01.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.

Authors:  Hao Liu; Yixue Gu; Hongsheng Wang; Jiang Yin; Guopei Zheng; Zhijie Zhang; Minyin Lu; Chenkun Wang; Zhimin He
Journal:  Oncotarget       Date:  2015-06-20

2.  Lymph node or perineural invasion is associated with low miR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma.

Authors:  Lucas O Sousa; Lays M Sobral; Camila S Matsumoto; Fabiano P Saggioro; Rossana V M López; Rodrigo A Panepucci; Carlos Curti; Wilson A Silva; Lewis J Greene; Andréia M Leopoldino
Journal:  BBA Clin       Date:  2016-11-05

3.  Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.

Authors:  Xu Chen; Peng Gu; Ruihui Xie; Jinli Han; Hao Liu; Bo Wang; Weibin Xie; Weijie Xie; Guangzheng Zhong; Changhao Chen; Shujie Xie; Ning Jiang; Tianxin Lin; Jian Huang
Journal:  J Cell Mol Med       Date:  2016-11-10       Impact factor: 5.310

4.  SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair Factors.

Authors:  Lulzim Shkreta; Johanne Toutant; Mathieu Durand; James L Manley; Benoit Chabot
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

5.  hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing.

Authors:  Wei-Zhao Peng; Ji-Xi Liu; Chao-Feng Li; Ren Ma; Jian-Zheng Jie
Journal:  Cancer Cell Int       Date:  2019-12-12       Impact factor: 5.722

6.  Crosstalk between hnRNP K and SET in ATRA-induced differentiation in acute promyelocytic leukemia.

Authors:  Karina Stringhetta Padovani; Renata Nishida Goto; Lais Brigliadori Fugio; Cristiana Bernadelli Garcia; Vani Maria Alves; Maria Sol Brassesco; Lewis Joel Greene; Eduardo Magalhães Rego; Andréia Machado Leopoldino
Journal:  FEBS Open Bio       Date:  2021-06-17       Impact factor: 2.693

7.  Association between SET expression and glioblastoma cell apoptosis and proliferation.

Authors:  Kunyan He; Lihong Shi; Tingting Jiang; Qiang Li; Yao Chen; Chuan Meng
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

8.  hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage.

Authors:  Alexandre Cloutier; Lulzim Shkreta; Johanne Toutant; Mathieu Durand; Philippe Thibault; Benoit Chabot
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  SE translation mRNA overexpression: a potential prognostic predictor in breast cancer.

Authors:  Qian Du; Ruifang Hao; Leichao Liu; Yang Liu; Siying Chen; Haisheng You; Ying Zhang; Yalin Dong
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.